When a deal cannot move, park it on purpose: say honestly it may not happen, offer two real paths with the cost of waiting spelled out, and write down the event that would bring it back.
The budget closed, a reorganisation started, or the security review will not begin until next quarter. The deal cannot move now, and chasing it will not change that.
Park it on purpose instead of letting it drift. Say out loud that it may not happen, without ending it: you hope it gets done and will work towards it, it is also possible it will not, so how much is it worth to them right now? Then offer two real paths, go ahead by a date, or park until a named date or event, and say in their terms what parking costs them. Write down the event that would bring it back, put the check in your own calendar rather than relying on theirs, and make every contact in between carry something they did not have before.
Two things are ruled out. The vague close, "let's stay in touch", which leaves the restart to the buyer's memory. And the note that tells the buyer you are closing their file.
Jason Lemkin's protocol for a deal on hold. Ask the champion directly why the hold happened: budget, a delay in the internal decision, or a shift in priorities. Add value without selling, such as a case study from a similar customer or news of a feature that hits the same pain. Watch for two events: a key decision maker leaving, in which case you go to the replacement, and a competitor of the buyer's making a move. Get in touch only when you have a reason. And no break-ups: never tell them you are closing their file or moving on.
The honest sentence, from medicine. Ariadne Labs' Serious Illness Conversation Guide, rewritten in 2023 after testing the words with patients, gives clinicians a line for an uncertain future in three parts: it is hard to predict what will happen; "I hope you will feel as well as possible for a long time", and we will work towards that; and it is also possible you could get sick quickly, so it is important to prepare. Its trade-off question asks how much the patient would be willing to go through for the possibility of more time. The sales version at the top of this entry, "I hope this gets done and I'll work towards it; it's also possible it won't; how much is it worth to you right now?", is the library's own rewrite, not something a seller has published. Patrick Lencioni's business fable Getting Naked makes the same case for consultants: enter the danger and tell the kind truth.
Two paths, with the cost of the second spelled out. In Punam Keller and colleagues' flu-shot study, plain active choice offered two boxes, I will get a flu shot this fall or I will not. Enhanced active choice added the consequences: the first box said the shot reduces the risk of flu and saves the $50 on offer, the second that the person accepts a higher risk and gives up the $50. Elmer Wheeler's 1937 rule for counter staff is the old sales version: don't ask if, ask which, one egg in the malted milk or two, never something against nothing.
The window you are watching for. Craig Elias and Tibor Shanto's preview chapter of SHiFT! names three states: happy with the status quo, unhappy but not looking yet, and actively looking. The "window of dissatisfaction" opens after an event makes the buyer decide what they have is no longer enough, and closes once they start searching.
Parking has not been measured. No study compares deals parked with a named trigger against deals left in a check-in cadence, or an honest hold conversation against pushing or a breakup email.
Being on the list when the window opens is what counts. Bain reported in June 2026, from a NewtonX survey of about 750 recent buyers in February 2026, that around 90% of buyers purchase from the list of suppliers they had in mind before the formal process started. The earlier Bain and Google survey of 1,208 people at US companies is described in Harvard Business Review. Bain sells growth advice. The job of every touch while the deal is parked is to keep you on that list.
The trigger-event numbers are the author's own. Elias reports, from his own 2003 survey of more than 200 sales managers and salespeople, close rates below 1% when the buyer is happy with the status quo, 10% to 20% once they are searching, and 60% to 90% when the seller arrives first inside the window. He sells the method and publishes no method for the survey.
The 95:5 rule is a rule of thumb. John Dawes' 2021 piece for the Ehrenberg-Bass Institute, commissioned by LinkedIn's B2B Institute, estimates the share of buyers in the market from how often they switch: about five years between changes of a main bank or law firm gives roughly 5% in any quarter. Dawes says himself, quoted by Sword and the Script, that the 95% is a heuristic to be recalculated for each category.
The honest question has a cost. The JOLT research on buyer indecision, summarised by Challenger, which sells the training built on it, found that the sellers who won stalled deals offered their own recommendation rather than leaving the buyer to work out the path. Asking how much effort the deal is worth hands that decision back, so ask it only when the deal really is parked, not while it is still moving.
A decision parked against a clear trigger mostly does not come back. In delayed prescribing, the patient gets the prescription with instructions to use it only if things have not settled by a stated point. Spurling and colleagues' Cochrane review, 12 trials and 3,968 people, found antibiotics used by 93% of those given them at once, 29% of those given the delayed prescription, and 13% of those given none, with satisfaction about the same: 88% delayed against 90% immediate. Parking did not cost the relationship, and most parked decisions were never taken up.
The honest conversation changed the conversations, not the outcome it aimed at. Rachelle Bernacki and colleagues randomised 91 oncology clinicians and 278 patients to a programme built on the Ariadne guide in 2019. Its two main outcomes, care matching patients' goals and peace at the end of life, did not improve. Anxiety and depression roughly halved at 14 weeks. Joanna Paladino and colleagues reported from the same trial that among patients who died, 96% had a documented serious conversation against 79%, held a median of 143 days before death against 71, covering their goals in 89% of cases against 44%. What was tested was a whole programme with training, not the sentence alone.
Two paths beat one ask, at least on paper. Keller and colleagues compared four ways of asking. In the first laboratory study, 42% said they would get the shot when asked to opt in, against 69% when they had to choose between two boxes. In the second, 93% asked for a reminder under enhanced active choice against 52% under plain active choice. In two field studies on prescription refills, enhanced active choice beat an opt-in default. Stephen Rains' review of reactance research found that controlling language produces anger and counter-arguing, which is the library's reason for offering a real choice rather than a push.
Both medical borrowings put the decision in one person's hands, while a parked B2B deal sits with a group whose members may have changed by the time the trigger fires. Nothing compares a parked deal with one left in a check-in cadence, and the only close rates attached to trigger events come from the author who sells the method.
When a deal cannot move, say so honestly, offer two real paths with the cost of waiting spelled out, and write down the event that would bring it back. Put the check in your own calendar, bring something new each time you get in touch, and never send "let's stay in touch" or "I'm closing your file". Expect most parked deals not to return, and keep yourself on the buyer's list for the ones that do.